Investor mix
18 investors on record; lead investors include Loayal Valley Capital, IDG Capital, Lilly Asia Ventures, Huagai Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 50% |
| Private equity | 6 | 33% |
| Other / undisclosed | 3 | 17% |
Developer of genome editing technology for the treatment of cancer and genetic disease
18 investors on record; lead investors include Loayal Valley Capital, IDG Capital, Lilly Asia Ventures, Huagai Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 50% |
| Private equity | 6 | 33% |
| Other / undisclosed | 3 | 17% |